Neuroprotective effects of MicroRNA-210 on hypoxic-ischemic encephalopathy

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Qiu, Jie ^a   Zhou, Xiao Yu ^a   Zhou, Xiao Guang ^a   Cheng, Rui ^a   Liu, Hai Ying ^a   Li, Yong ^a  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; MICRORNA 210; NEUROPROTECTIVE AGENT; PROTEIN BAX; PROTEIN BCL 2; MICRORNA; MIRN21 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PERINATAL PERIOD; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BRAIN; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SYNTHESIS;

ANIMALS; APOPTOSIS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MICRORNAS; NEUROPROTECTIVE AGENTS; RATS;

EID: 84884835799     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/350419     Document Type: Article

References (19)

1. Ivan M., Harris A. L., Martelli F., Kulshreshtha R., Hypoxia response and microRNAs: no longer two separate worlds. Journal of Cellular and Molecular Medicine 2008 12 5 1426 1431 2-s2.0-54049105673 10.1111/j.1582-4934.2008.00398.x
2. Chan S. Y., Loscalzo J., MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010 9 6 1072 1083 2-s2.0-77953483108
3. Camps C., Buffa F. M., Colella S., Moore J., Sotiriou C., Sheldon H., Harris A. L., Gleadle J. M., Ragoussis J., Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clinical Cancer Research 2008 14 5 1340 1348 2-s2.0-40949137731 10.1158/1078-0432.CCR-07-1755 (Pubitemid 351413913)
4. Jeyaseelan K., Lim K. Y., Armugam A., MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008 39 3 959 966 2-s2.0-41249102422 10.1161/STROKEAHA.107.500736 (Pubitemid 351619577)
5. Liu D., Tian Y., Ander B. P., Xu H., Stamova B. S., Zhan X., Turner R. J., Jickling G., Sharp F. R., Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. Journal of Cerebral Blood Flow and Metabolism 2010 30 1 92 101 2-s2.0-73949091031 10.1038/jcbfm.2009.186
6. Fasanaro P., D'Alessandra Y., Di Stefano V., Melchionna R., Romani S., Pompilio G., Capogrossi M. C., Martelli F., MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. The Journal of Biological Chemistry 2008 283 23 15878 15883 2-s2.0-47049119934 10.1074/jbc.M800731200
7. Love T. M., Moffett H. F., Novina C. D., Not miR-ly small RNAs: big potential for microRNAs in therapy. Journal of Allergy and Clinical Immunology 2008 121 2 309 319 2-s2.0-38849209304 10.1016/j.jaci.2007.12.1167 (Pubitemid 351215186)
8. Weiler J., Hunziker J., Hall J., Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Therapy 2006 13 6 496 502 2-s2.0-33645135862 10.1038/sj.gt.3302654
9. Orom U. A., Kauppinen S., Lund A. H., LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 2006 372 1-2 137 141 2-s2.0-33646027887 10.1016/j.gene.2005.12.031
10. Hu S., Huang M., Li Z., Jia F., Ghosh Z., Lijkwan M. A., Fasanaro P., Sun N., Wang X., Martelli F., Robbins R. C., Wu J. C., MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010 122 supplement 11 S124 S131 2-s2.0-77957243894 10.1161/CIRCULATIONAHA.109.928424
11. Pulera M. R., Adams L. M., Liu H., Santos D. G., Nishimura R. N., Yang F., Cole G. M., Wasterlain C. G., Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke 1998 29 12 2622 2630 2-s2.0-0031782899 (Pubitemid 28544015)
12. Giannakakis A., Sandaltzopoulos R., Greshock J., Liang S., Huang J., Hasegawa K., Li C., O'Brien-Jenkins A., Katsaros D., Weber B. L., Simon C., Coukos G., Zhang L., miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biology and Therapy 2008 7 2 255 264 2-s2.0-42549092314 (Pubitemid 351590433)
13. Zeng L., Liu J., Wang Y., Wang L., Weng S., Tang Y., Zheng C., Cheng Q., Chen S., Yang G., MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Frontiers in Bioscience 2011 3 1265 1272 2-s2.0-80053590072
14. van den Tweel E. R. W., Kavelaars A., Lombardi M. S., Nijboer C. H. A., Groenendaal F., van Bel F., Heijnen C. J., Bilateral molecular changes in a neonatal rat model of unilateral hypoxic-ischemic brain damage. Pediatric Research 2006 59 3 434 439 2-s2.0-33646089225 10.1203/01.pdr.0000200799.64038.19 (Pubitemid 43740084)
15. Mu D., Jiang X., Sheldon R. A., Fox C. K., Hamrick S. E. G., Vexler Z. S., Ferriero D. M., Regulation of hypoxia-inducible factor 1 α and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiology of Disease 2003 14 3 524 534 2-s2.0-0347479363 10.1016/j.nbd.2003. 08.020 (Pubitemid 37543530)
16. Kulshreshtha R., Ferracin M., Wojcik S. E., Garzon R., Alder H., Agosto-Perez F. J., Davuluri R., Liu C., Croce C. M., Negrini M., Calin G. A., Ivan M., A microRNA signature of hypoxia. Molecular and Cellular Biology 2007 27 5 1859 1867 2-s2.0-33847234988 10.1128/MCB.01395-06
17. Chopp M., Li Y., Apoptosis in focal cerebral ischemia. Acta Neurochirurgica, Supplement 1996 66 21 26 2-s2.0-0029691054 (Pubitemid 126440523)
18. Pardridge W. M., Intravenous, non-viral RNAi gene therapy of brain cancer. Expert Opinion on Biological Therapy 2004 4 7 1103 1113 2-s2.0-3142731321 10.1517/14712598.4.7.1103 (Pubitemid 38937552)
19. Pardridge W. M., shRNA and siRNA delivery to the brain. Advanced Drug Delivery Reviews 2007 59 2-3 141 152 2-s2.0-34248679586 10.1016/j.addr.2007.03. 008 (Pubitemid 46773051)